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Summary Chinese hamster V79-171B spheroids implanted in the peritoneal cavity of C3H mice were
characterized as a model for evaluating the toxicity of drugs requiring metabolic activation in vivo. After 24
hours in the peritoneal cavity, spheroid cellularity and plating efficiency were not significantly decreased, and
host cell infiltration was estimated between 5 and 10%. The oxygenation of spheroids in the peritoneal cavity
was assessed using their response to ionizing radiation. Spheroids were recovered after irradiation, incubated
for 20 minutes in vitro with the slowly penetrating fluorescent dye, Hoechst 33342, and reduced to single cells
with trypsin. Cells were analysed for clonogenicity as a function of position within the spheroid by using
fluorescence-activated cell sorting in conjunction with the Hoechst diffusion gradient. When spheroids were
first placed in the peritoneal cavity, the hypoxic fraction was close to 100%, but after 24 hours, cell
oxygenation increased, probably due to a decrease in cell respiration rate. However, the location of a spheroid
within the peritoneal cavity did not influence the radiosensitivity of individual spheroids or the amount of
Hoechst 33342 delivered to the spheroid when Hoechst was given intravenously; individual spheroids
recovered from mice given an intravenous injection of Hoechst showed no greater heterogeneity in binding
than that observed when spheroids were incubated with Hoechst in vitro. Mice implanted with spheroids were
also exposed to cyclophosphamide; the external cells of 0.6mm diameter spheroids were about 30% more
sensitive than the internal cells to the toxic effects of both cyclophosphamide and X-rays, and the
combination of the two agents was additive at all depths within the spheroid.
Multicellular spheroids represent a valuable experimental
tool for analysing the effects of various anticancer treatments
in vitro (Sutherland & Durand, 1976; Acker et al., 1984). A
limitation of this model, however, is the lack of drug
activating systems in vitro. Thus, drugs such as cyclophos-
phamide, which require metabolic activation by liver
enzymes, cannot be easily studied. Providing drug-activating
enzymes to spheroids growing in suspension culture by using
liver homogenates or intact liver cells presents additional
problems of drug dosage and effects of cytolytic enzymes on
the target cells. An alternate approach is to implant the
spheroids directly into the peritoneal cavity of mice. The
drug can then undergo activation and react with spheroids
under more natural conditions.
Initial studies of host effects on spheroids placed in the
peritoneal cavity were conducted several years ago by
MacDonald and Howell (1978) with the goal of developing a
quantitative model for the assessment of in situ immunity to
solid tumour allografts. In the absence of preimmunization,
several days were required for the mouse to mount an
immune response to the spheroids. By retrieving the
spheroids (EMT6 or HT-29) from the peritoneal cavity of
mice within 24h of injection, no change in tumour cell
recovery or plating efficiency was observed (Lord, 1980; Lees
et al., 1981). The first use of spheroids placed i.p. to access
the toxicity of chemotherapeutic agents was described by
Yuhas et al. (1978). These authors evaluated growth rates of
intact MCa-11 spheroids after removal from the peritoneal
cavity of BALB/c mice; treatment of mice with 100mgkg-1
cyclophosphamide with removal of spheroids 4h later
resulted in a 6 day growth delay and 25% cure (no growth
in 25% of the spheroids). The subpopulations responding to
this treatment and the mechanisms for growth delay (cell
killing or mitotic inhibition) were not determined.
Cyclophosphamide is the most widely-used alkylating
agent in cancer therapy. While non-toxic to tumour cells in
vitro, cyclophosphamide undergoes oxidation to 4-hydroxy-
cyclophosphamide in the liver, and this metabolite breaks
down spontaneously to the active alkylating agent
phosphoramide mustard and acrolein (Cox, 1973). Previous
studies on the interaction between damage by X-rays and
cyclophosphamide have led to contradictory conclusions
(Parker, 1979; Steel & Peckham, 1979; Lelieveld et al., 1985;
Byfield et al., 1986). There is no doubt that combining these
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two agents results in a greater effect than either agent given
alone, but whether this response is more than additive has
not been fully resolved. Since interpretation of interactive
damage in spheroids should be far simpler than analysis of
damage in tumours, Chinese hamster V79 spheroids, placed
in the peritoneal cavity of mice, were used as a target for
damage by ionizing radiation and cyclophosphamide. Using
the cell sorting method of Durand (1982, 1986b) to select
cells from different depths within the spheroid, information
on relative sensitivity of cells throughout the spheroid was
obtained.
Materials and methods
Chinese hamster V79-171b lung fibroblasts were maintained
as exponentially-growing monolayer cultures by passaging
biweekly in minimal essential medium containing 10% foetal
bovine serum. Spheroids were initiated and grown in
suspension culture as previously described (Sutherland &
Durand, 1976). Batches of spheroids between 0.6 and 0.7mm
diameter were washed several times in PBS, resuspended at a
density of 100 spheroids/0.5ml saline, then slowly injected,
using a 18 gauge needle, into the peritoneal cavity of 10-12
week-old female C3H mice. Two hours later, mice bearing
spheroids received i.p. injections of cyclophosphamide in
0.5 ml saline. Since activation of cyclophosphamide to a
toxic drug occurs only in the liver, injection of this drug into
the peritoneal cavity containing spheroids does not result in
a heterogeneous drug exposure. Mice containing spheroids
were given whole-body X-irradiation at a dose rate of
1.37Gymin- 1 given either I h or -20h after implantation
of spheroids. In vitro exposures were given at the same dose
rate using spheroids held at 4°C.
Twenty hours after injection of spheroids (- 100
spheroids/mouse), mice were killed by cervical dislocation,
the peritoneal cavity was opened and spheroids were
removed aseptically by lavage. Spheroids were rinsed in
complete medium and incubated with 2pM Hoechst 33342 in
petri dishes on an orbital shaker at 37°C. After 20min in
Hoechst 33342, spheroids were washed and incubated in
0.25% trypsin for 8 min. They were then disaggregated by
vigorous pipetting. Single cell suspensions were analysed
using flow cytometry.
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A Becton Dickinson FACS 440 dual argon laser cell sorter
was used to sort spheroid cells according to the Hoechst
33342 concentration gradient as previously described
(Durand, 1982, 1983, 1986b). Cells were sorted into 10
windows each representing 10% of the cells within the
population; knowing the spheroid diameter, the average
depth of a fraction within the spheroid was calculated.
Defined numbers of cells were sorted into tubes which were
poured directly into petri plates to improve accuracy of
sample counting (Durand, 1986a); the within experiment
variability is less than the symbol size on the figures. No
influence of Hoechst 33342 on the plating efficiency of the
spheroid cells was observed. Colonies were stained and
counted 8 days later. Results obtained using different
batches of spheroids were not averaged, but experiments
were repeated two or more times at selected doses with
excellent reproducibility between experiments. For clarity,
only two independent experiments are displayed for any one
dose.
tetraploid spheroids exposed to the peritoneal cavity of mice
for 24h (Figure 1). The host cell contamination of spheroids
was estimated between 5 and 10% by measuring the
percentage of cells with less than the G1 tetraploid DNA
content.
In order to characterize the oxygenation of spheroids
implanted in the peritoneal cavity, the response of spheroids
to ionizing radiation was measured. Spheroids irradiated 20h
after implantation into the peritoneal cavity showed more
damage in the external than internal cell fractions for all
radiation doses (Figure 2). While this is the expected
response when external cells are oxygenated and internal
cells are hypoxic, the differential in survival through the
spheroid was much smaller than expected. In vitro studies
with spheroids have shown a differential of 20 (consistent
with an OER of 2.8) between the surviving fraction of
internal (hypoxic) and external (oxic) cells of spheroids
exposed to 15 Gy (Durand, 1983), not a factor of 5 as shown
here.
10.
Results
The average plating efficiency of cells recovered from
spheroids placed in the peritoneal cavity was unchanged
compared to spheroids maintained in vitro, although in 2 out
of 8 experiments, the plating efficiency of the innermost
fraction (l10% of the cells) was decreased by 20%. No
significant change in the number of cells recovered per
spheroid relative to the in vitro control (accuracy with
+ IO%) was observed for i.p. incubations up to 20h. Since
the numbers of infiltrating non-clonogenic host cells could
be significant (Lees et al., 1981), it seems likely that the flow
cytometer was able to discriminate between V79 and host
cells on the basis of cell size. It is also likely that the
vigorous pipetting used to dissociate spheroid cells resulted
in some host cell loss.
To determine the fraction of host cells present in
spheroids, a tetraploid clone from our V79 cell line was used
to form spheroids which were injected i.p. Twenty-four
hours later, the spheroids were recovered, reduced to single
cells and stained for DNA content using the Vindelov (1977)
procedure. DNA histograms were generated for diploid cells
from unfed cultures, tetraploid spheroid cells maintained in
vitro. tetraploid cells mixed with 10% diploid cells, and
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Figure 1 DNA flow histograms of V79 cells and tetraploid
spheroids. Spheroids were trypsinized and cells stained with a
detergent/ethidium bromide solution. Nuclei were examined flow
cytometrically for DNA content. Profile (a) is the DNA content
of nuclei of diploid V79 cells with >90% GI cells, profile (b) is
DNA content from tetraploid spheroids mixed with 10% diploid
cells, profile (c) is DNA from tetraploid spheroids maintained in
vitro and profile (d) is DNA from tetraploid spheroids
maintained in the peritoneal cavity of C3H mice for 24h. The
diploid peak in profile (d) represents host cells. Each unit on the
abscissa represents 10 channels, and areas under the curve are
constant.
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Figure 2 Cytotoxicity of X-rays towards V79 spheroids
implanted in the peritoneal cavity of C3H mice. In the left hand
panel, the clonogenicity of cells sorted from different depths
within the spheroid exposed to increasing doses of X-rays is
shown. *=0OGy; A= 5Gy; =10Gy; A =15Gy; V =2OGy;
x=25 Gy. The horizontal lines represent the average response. In
the right hand panel, the average response of cells of spheroids
(0), the inner 10% of cells (A), and the outer 10% of cells (V)
is shown.
One possible explanation for this result is that spheroid
cells are much more radiosensitive after 20 h in the
peritoneal cavity. To examine this possibility, spheroids were
implanted into the peritoneal cavity 20h before irradiation,
and 5 min before irradiation, mice were asphyxiated by
breathing nitrogen (Figure 3). The radiation survival of cells
from these spheroids was not significantly different from
previous in vitro results with anoxic spheroids (Durand,
1983), indicating that incubation of spheroids within the
peritoneal cavity for 20 h did not alter their inherent
radiation sensitivity. Interestingly, all of the spheroid cells
were more resistant to radiation 1 h after being placed in the
peritoneal cavity than 20h later. The dose-response curves in
Figure 3 (right hand panel) indicated that all of the cells
were anoxic from spheroids from asphyxiated mice,
spheroids incubated for only 1 h were slightly more radio-
sensitive, but those maintained in the peritoneal cavity for
20 h appeared to contain cells at an intermediate oxygen
tension. After 20h, none of the cells appeared fully oxic or
anoxic.
The presence of cells at an intermediate radiosensitivity at
all positions within the spheroid seems inconsistent with
oxygen diffusion theory unless either (1) spheroid
respiration is considerably reduced after 20 h in the
peritoneal cavity so that the small amount of available
oxygen is able to reach the central cells of the spheroid, or
(2) some spheroids in the peritoneal cavity are anoxic and
some are oxic, and by combining all spheroids for Hoechst
33342 staining in vitro, an averaging occurs resulting in a
loss of the correlation between Hoechst staining intensity
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Figure 3 Radiation response of spheroids in the peritoneal
cavity of mice. In the left hand panel, the clonogenicity of cells
sorted from different depths within the spheroid is shown after
irradiation with 15Gy while in the peritoneal cavity, or in vitro
at 4 C(@). Horizontal lines are the average response. In the right
hand panel, the average response is shown for spheroids
irradiated in vitro at 4°C (the oxic response; *), in vivo 20h after
implantation and 5min after asphyxiation (V)? 1 h after
implantation (A), or 20h after implantation (x).
and oxygenation status. The latter explanation seems
reasonable since some spheroids appeared to be located in
pools beneath the liver lobes, while others seem adsorbed
onto the surface of the gut. An experiment was devised to
address this question by injecting 75jugg-1 Hoechst 33342
i.v. into a mouse 20h after injection with spheroids. Since
the plasma half-life of Hoechst 33342 is less than 2min
(Olive et al., 1985), dye binding by the spheroids will occur
very rapidly (i.e. before significant movement of a spheroid
from its location should occur). Spheroids were recovered
within 20min and 24 spheroids were individually trypsinized
and analysed to determine the distribution of Hoechst 33342
intensity within each spheroid. If some spheroids are located
in areas of the peritoneal cavity which are better perfused,
then the Hoechst fluorescence intensity in these spheroids
should be greater than the intensity in spheroids with less
access to nutrients. As can be seen in Figure 4, the hetero-
geneity in Hoechst 33342 fluorescence intensities of spheroids
labelled via blood perfusion was small and was not greater
than that seen when spheroids were incubated with Hoechst
in Petri dishes (note that the absolute intensity differs in vivo
and in vitro since spheroids were exposed to different doses
of Hoechst). This suggests that all spheroids in vivo were
exposed to the same amount of Hoechst, and by inference,
to the same amount of oxygen. Thus, the location of a
spheroid within the peritoneal cavity does not appear to be
responsible for the presence of hypoxic cells at all depths
within the spheroid, provided that oxygen delivery in the
peritoneal cavity parallels that of the Hoechst dye.
While the results shown in Figure 4 can be interpreted to
mean that oxygen availability is probably similar for
individual spheroids in vivo, the possibility remains that
differences in the rate at which oxygen is consumed by
individual spheroids could cause an averaging of responses
in cells sorted according to the Hoechst diffusion gradient.
To examine this question, spheroids were trypsinized
individually after receiving 15 Gy within the peritoneal
cavity; the average surviving fraction (not corrected for
plating efficiency) was 0.086+0.021 (mean+s.d. for 24
spheroids). This small degree of variation indicates that all
of the spheroids were at roughly the same oxygenation at the
time of irradiation.
Chinese hamster V79 spheroids exposed to cyclophos-
phamide in the peritoneal cavity showed progressive cell kill
with increasing doses of cyclophosphamide; internal non-
cycling cells appeared more resistant to the cytotoxic effects
of high doses of cyclophosphamide (Figure 5). The ratio of
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Figure 4 Heterogeneity in Hoechst 33342 intensity through the
spheroid. Spheroids were implanted for 20h in the peritoneal
cavity and were exposed to Hoechst 33342 either in vivo, by i.v.
injection of 75jugg-1 and sacrifice 20min later, or in vitro, by
incubation with 2 ugml-1 for 20min. Cells from 24 spheroids
were examined individually for the distribution of Hoechst 33342
using flow cytometry. The mean+s.d. is shown, and for those
symbols without s.d. bars, the s.d. is less than the symbol size.
Horizontal lines are the average response.
the slopes of the dose-response curves for the inner and
outer 10% of cells was 1.3.
The combination of X-rays with cyclophosphamide is
shown in Figure 6. In the left hand panel, spheroids received
15 Gy plus increasing doses of cyclophosphamide. The effects
appear additive at all depths within the spheroid. In the right
hand panel, the effects of increasing doses of X-rays are
shown for the average response of the spheroid cells; again,
toxicity appears additive at all doses.
Discussion
Spheroids placed in the peritoneal cavity of mice appear to
be a good model for assessing the cytotoxic effects of drugs
such as cyclophosphamide which require metabolic
activation by liver enzymes. The doses of cyclophosphamide
were chosen on the basis of observed cytotoxic effects in vivo
with 100mgkg-' producing 1-2 logs of cell kill in many
transplantable mouse tumours. Since 1-2 logs of cell kill was
observed with double this dose in implanted spheroids
(Figure 4a), the amount of activated drug reaching the
spheroids in the peritoneal cavity was probably decreased
only two-fold.
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Figure 5 Cytotoxicity of cyclophosphamide to Chinese hamster
V79 spheroids implanted in the peritoneal cavity of C3H mice.
Spheroids were exposed i.p. to doses of cyclophosphamide (50-
200mgkg-1) and recovered after 20h. Clonogenicity of cells
sorted from different depths within the spheroid was determined
using fluorescent-activated cell sorting in conjunction with the
Hoechst 33342 diffusion gradient. Horizontal lines represent the
average response for cells from spheroids. In the right hand
panel, the average response of the spheroid cells (0), the inner
10% of cells (A), or the outer 10% of cells (V) is shown.324 P.L. OLIVE
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Figure 6 Cytotoxicity to implanted spheroids by the
combination of cyclophosphamide and X-rays. Spheroids were
examined for clonogenicity as a function of depth into the
spheroid following doses of cyclophosphamide given i.p. 18 h
prior to irradiation. The horizontal lines represent the average
response. In the left hand panel, the responses of spheroids given
15 Gy to increasing doses of cyclophosphamide are shown. In the
right hand panel, the average responses of spheroid cells are
plotted.
The pattern of cytotoxicity of cyclophosphamide to
spheroids is similar to the response seen with the direct
acting alkylating agents, MNNG (Olive, 1986) and
chlorambucil (Durand, 1986b); the external cycling cells are
slightly more sensitive to the toxic effects of these drugs
(Figure 2). Results combining X-rays and activated cyclo-
phosphamide support previous studies which showed only
additivity in action between X-rays and cyclophosphamide
(Byfield et al., 1986). One possible explanation for previous
conflicting results is that cell subpopulations within tumours
responded differently to the combined treatment. However,
results shown in Figure 6 indicate additivity at all depths
within the spheroid, and thus for cycling as well as non-
cycling cells, and for oxic as well as hypoxic cells.
The X-ray response revealed important information on the
oxygenation of spheroids in the peritoneal cavity. While
spheroids were anoxic when first implanted, they may have
adapted to conditions within the peritoneal cavity. Radiation
survival curves showed that there were no uniformly oxic
cells and no uniformly anoxic cells in spheroids which were
implanted for 20 h (Figure 3). Since the anoxic response
from asphyxiated mice (Figure 3) was virtually identical to
the in vitro anoxic response (Durand, 1983), the cells were
not simply more radiosensitive. The simplest explanation for
this observation is that the respiration rate of spheroid cells
decreases under these adverse conditions. A number of
factors, including cell respiration rate, have been shown to
influence oxygen distributions in spheroids (Biaglow &
Durand, 1976; Acker et al., 1984) and the role of infiltrating
host cells on spheroid oxygenation and respiration has not
been assessed. However, the fraction of host cells infiltrating
V79 spheroids during the first 24h is between 5 and 10%,
and therefore much smaller than the 70% observed using
EMT6 spheroids (Lord & Burkhardt, 1984). Variability in
spheroid penetration by host cells was also apparent in
studies by Yuhas et al. (1978), where there was a 4 day
growth delay in one cell line but no delay in another after
spheroids were recovered from the peritoneal cavity. It is
possible that the tight cell packing in V79 spheroids is
contributing to this low host cell infiltration.
Spheroids placed in the peritoneal cavity of mice could
also provide a useful 'internal control' in experiments with
transplantable tumours in mice using tumour excision assays.
Because of transient blood flow changes, effects of tumour
microvasculature, drug pharmacokinetics, cell loss and
repopulation, reoxygenation etc., results in animal models
are not always easy to interpret in a mechanistic fashion.
Examination of the response of spheroids implanted within
the same mice to a combination treatment could provide
rapid information on changes in drug availability, the extent
of drug penetration and perhaps most importantly, the
occurrence of cell loss.
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